influenza virus vaccine 2025-2026 (trivalent - Croatia/Victoria/Austria) 0.5 ML Prefilled Syringe
- RxCUI
- 2718386
- RxNorm name
- influenza virus vaccine 2025-2026 (trivalent - Croatia/Victoria/Austria) 0.5 ML Prefilled Syringe
- Display name
- influenza virus vaccine 2025-2026 (trivalent - Croatia/Victoria/Austria) 0.5 ML Prefilled Syringe
- Full name
- influenza virus vaccine 2025-2026 (trivalent - Croatia/Victoria/Austria) 0.5 ML Prefilled Syringe
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:11
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125254 | Afluria, Afluria Quadrivalent | Influenza Vaccine | 351(a) | Disc | 2026-08-01 |
| 125510 | Fluad | Influenza Vaccine, Adjuvanted | 351(a) | Disc | 2026-08-01 |
| 125163 | Flulaval, Flulaval Quadrivalent | Influenza Vaccine | 351(a) | Rx | 2026-08-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a06c4ead-c988-4b10-b832-4d7460fa358f | influenza virus vaccine 2025-2026 (trivalent - Croatia/Victoria/Austria) 0.5 ML Prefilled Syringe [PSN] · 0.5 ML influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML Prefilled Syringe [SCD] · influenza virus vaccine 2025-2026 (trivalent - Croatia/Victoria/Austria) 0.5 ML Prefilled Syringe [SY] | 3 | 16 | These highlights do not include all the information needed to use AFLURIA ® safely and effectively. See full prescribing information for AFLURIA. AFLURIA (Influenza Vaccine) Injectable Suspension, for Intramuscular Use 2025-2026 Formula Initial U.S. Approval: 2007 | 20260309 |
| dccfb747-8f64-46ec-3993-95195b585581 | influenza virus vaccine 2025-2026 (trivalent - Croatia/Victoria/Austria) 0.5 ML Prefilled Syringe [PSN] · 0.5 ML influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML Prefilled Syringe [SCD] · influenza virus vaccine 2025-2026 (trivalent - Croatia/Victoria/Austria) 0.5 ML Prefilled Syringe [SY] | 3 | 15 | These highlights do not include all the information needed to use FLULAVAL safely and effectively. See full prescribing information for FLULAVAL. FLULAVAL (Influenza Vaccine) Injectable Suspension, for Intramuscular Use 2025-2026 Formula Initial U.S. Approval: 2006 | 20260306 |
| 9dbbf304-7be3-4417-8285-a8f5fd20f977 | influenza virus vaccine 2025-2026 (trivalent - Croatia/Victoria/Austria) 0.5 ML Prefilled Syringe [PSN] · 0.5 ML influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML Prefilled Syringe [SCD] · influenza virus vaccine 2025-2026 (trivalent - Croatia/Victoria/Austria) 0.5 ML Prefilled Syringe [SY] | 3 | 13 | These highlights do not include all the information needed to use FLUAD ® safely and effectively. See full prescribing information for FLUAD. FLUAD (Influenza Vaccine, Adjuvanted) Injectable Emulsion for Intramuscular Use 2025-2026 Formula Initial U.S. Approval: 2015 | 20250701 |